Myasthenia Gravis in a Chronic Spinal Cord Injury Patient: Case Report

Authors

  • Carolina Lourenço Centro de Medicina de Reabilitação da Região Centro - Rovisco Pais, Tocha, Portugal
  • Adriana Pascoal Centro de Medicina de Reabilitação da Região Centro - Rovisco Pais, Tocha, Portugal
  • Luís Gil Andrade Centro de Medicina de Reabilitação da Região Centro - Rovisco Pais, Tocha, Portugal
  • Filipe Félix Morais Centro de Medicina de Reabilitação da Região Centro - Rovisco Pais, Tocha, Portugal
  • Paulo Margalho Centro de Medicina de Reabilitação da Região Centro - Rovisco Pais, Tocha, Portugal
  • Jorge Laíns Centro de Medicina de Reabilitação da Região Centro - Rovisco Pais, Tocha, Portugal

DOI:

https://doi.org/10.25759/spmfr.426

Keywords:

Botulinum Toxins, Type A/therapeutic use, Muscle Spasticity, Myasthenia Gravis, Spinal Cord Injuries

Abstract

Myasthenia gravis (MG) is an acquired autoimmune disorder characterized by fluctuating weakness and fatigability of skeletal muscle that is worse by the end of the day. We report a very rare case of a patient with a previous spinal cord injury (SCI) that was diagnosed with MG.

A 50-year-old man with AIS C quadriplegia, neurologic level C5, a central cord syndrome of traumatic etiology with an intrathecal baclofen pump and the need of regular botulinum toxin application in the upper limbs due to severe spasticity. In August 2018 he started complaining of fluctuating diplopia, headache, dysphagia, hypophonia and muscular weakness. Due to MG suspicion, he was admitted in October 2018 in a Neurology ward.

The complementary exams detected antibodies to the acetylcholine receptor and a decreasing response in repetitive nerve stimulation confirmed the diagnostic. He started treatment with corticosteroids and immunoglobulin with clinical improvement.

Since botulinum toxin worsens MG symptoms, it was not further applied, limiting spasticity treatment and deteriorating his functionality.

This case reports the coexistence of two unusual simultaneous entities: SCI and MG. The patient presented an incomplete SCI and severe spasticity which difficulted management of both pathologies, making this case uniquely challenging.

Downloads

Download data is not yet available.

References

Gilhus NE. Myasthenia Gravis. N Engl J Med. 2016;375:2570-81. doi:

1056/NEJMra1602678.

Hehir MK, Silvestri NJ. Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology. Neurol Clin. 2018;36:253- 60. doi: 10.1016/j.ncl.2018.01.002.

Kolli S, Mathew KM, Thumbikat P, McClelland MR, Nair KP. Superimposed myasthenia gravis in chronic spinal cord injury: a case report. Spinal Cord. 2011;49:1206-7. doi: 10.1038/sc.2010.182.

Werner P, Kiechl S, Löscher W, Poewe W, Willeit J. Distal myasthenia gravis – frequency and clinical course in a large prospective series. Acta Neurol Scand. 2003: 108:209–11. doi: 10.1034/j.1600-0404.2003.00136.x.

Glick ZR, Vaphiades MS, Northington ME. OnabotulinumtoxinA Unmasking Myasthenia Gravis. Dermatol Surg. 2013;39:472–3. doi: 10.1111/dsu.12022.

Liik M, Punga AR. Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation. Clin Neurophysiol Pract. 2020;5:46–9. doi: 10.1016/j.cnp.2020.01.002.

Ma Q, Ran H, Ou C, Liu X, Lu Y, Huang H, et al. Is myasthenia gravis a contraindication for botulinum toxin? J Clin Neurosci. 2022;95:44-7. doi: 10.1016/j.jocn.2021.11.010.

Khan F, Amatya B, Bensmail D, Yelnik A. Non-pharmacological interventions for spasticity in adults: An overview of systematic reviews. Ann Phys Rehabil Med. 2019;62:265-73. doi: 10.1016/j.rehab.2017.10.001.

Yang E, Lew HL, Özçakar L, Wu CH. Recent Advances in the Treatment of Spasticity: Extracorporeal Shock Wave Therapy. J Clin Med. 2021;10:4723. doi: 10.3390/jcm10204723.

Downloads

Published

2023-04-05

How to Cite

1.
Lourenço C, Pascoal A, Andrade LG, Morais FF, Margalho P, Laíns J. Myasthenia Gravis in a Chronic Spinal Cord Injury Patient: Case Report. SPMFR [Internet]. 2023 Apr. 5 [cited 2024 Nov. 22];35(1):29-31. Available from: https://spmfrjournal.org/index.php/spmfr/article/view/426

Issue

Section

Case Report

Similar Articles

<< < 2 3 4 5 6 7 8 9 10 11 > >> 

You may also start an advanced similarity search for this article.